Tick-borne diseases (TBDs) have become a global public health challenge. In recent years, both tick-borne pathogens and TBD cases have increased globally. TBDs are the most common vector-borne diseases in the US with Lyme disease being the most reported TBD. Furthermore, tick surveys have shown that tick populations have expanded to new areas of the country at a rapid rate. As more cases are being reported, it is critical to detect TBDs accurately and rapidly in order to provide early treatment. In this webinar, Dr. Theel discusses TBDs and how to detect them based on disease type, infection stage, and testing availability.
Dr. Elitza S. Theel, PhD, D(ABMM)
Director of Infectious Diseases Serology Laboratory
Co-Director of the Vector-Borne Diseases Service Line
Mayo Clinic – Rochester, MN
To view this webinar, please complete the following form.
2024 EUROIMMUN US
